image
Ascendis Pharma A/S ASND
Healthcare - Biotechnology - NASDAQ - DK
Watchlist
$ 126.51
1.79 %
$ 7.26 B
Market Cap
-13.89
P/E
INCOME STATEMENT
267 M REVENUE
421.20%
Growth Rates
1Year 421.20%
3Years 237.26%
5Years 90.68%
7Years 78.57%
10Years 29.31%
-456 M OPERATING INCOME
18.92%
Growth Rates
1Year 18.92%
3Years -11.28%
5Years -24.10%
7Years -29.92%
10Years -56.35%
-481 M NET INCOME
17.45%
Growth Rates
1Year 17.45%
3Years -4.74%
5Years -29.91%
7Years -32.12%
10Years -61.27%
EFFICIENCY
Earnings Waterfall Ascendis Pharma A/S
image
Revenue 267 M
Cost Of Revenue 44.4 M
Gross Profit 222 M
Operating Expenses 678 M
Operating Income -456 M
Other Expenses 25.9 M
Net Income -481 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 266.7 51.2 7.8 7.0 13.4 10.6 1.5 4.6 8.1 14.0 20.4 15.6
GROSS PROFIT
Cost Of Revenue 44.4 12.1 3.5 0 0 0 0 0 0 0 0 0
Gross Profit 222.3 39.0 4.3 7.0 13.4 10.6 1.5 4.6 8.1 14.0 20.4 15.6
OPERATING INCOME
Operating Expenses 677.9 600.9 456.0 337.6 240.1 165.3 113.1 77.5 49.9 26.0 15.1 14.1
Selling, General and Administrative Expenses 264.4 221.2 160.2 76.7 48.5 25.1 13.5 11.5 9.4 6.3 2.4 2.7
Research and Development Expenses 413.5 379.6 295.9 260.9 191.6 140.3 99.6 66.0 40.5 19.7 12.7 11.4
Operating Income (455.5) (561.8) (451.8) (330.6) (226.7) (154.8) (111.5) (72.9) (41.8) (12.0) 5.3 1.5
PRE-TAX INCOME
Interest Income Expense 44.1 50.5 3.9 1.9 1.2 0.1 97 K 5 K 6 K 16 K 8 K 20 K
Total Other Income (18.6) (16.0) 67.8 (88.6) 8.5 24.3 (12.8) 4.2 8.3 1.6 (0.6) (0.2)
Pre-Tax Income (474.1) (577.8) (383.9) (419.2) (218.2) (130.5) (124.4) (68.7) (33.6) (10.3) 4.7 1.3
NET INCOME
Tax Provision 7.3 5.4 (0.4) (0.2) (0.2) (0.4) (0.5) (0.2) (0.7) (0.7) 0.6 35 K
Net Income (481.4) (583.2) (383.6) (419.0) (218.0) (130.1) (123.9) (68.5) (32.9) (9.7) 4.1 1.2
EPS 8.55 10.4 7 8.28 4.69 3.17 3.68 2.58 1.39 0.57 0.38 0.12